Trajectories of Body Mass Index and Risk for Diabetes Complications and All-Cause Mortality in Finnish Type 2 Diabetes Patients
DOI: https://doi.org/10.2147/clep.s450455
2024-03-30
Clinical Epidemiology
Abstract:Zhiting Wang, 1 Piia Lavikainen, 2 Katja Wikström, 1, 3 Tiina Laatikainen 1, 3, 4 1 Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland; 2 School of Pharmacy, University of Eastern Finland, Kuopio, Finland; 3 Department of Public Health and Welfare, Finnish Institute for Health and Welfare, Helsinki, Finland; 4 Joint Municipal Authority for North Karelia Social and Health Services, Joensuu, Finland Correspondence: Zhiting Wang, Institute of Public Health and Clinical Nutrition, University of Eastern Finland, PO Box 1627, Kuopio, 70211, Finland, Tel +358 469589963, Email Objective: We aimed to assess how longitudinal body mass index (BMI) trajectories are associated with diabetes complications and all-cause mortality in Finnish patients with type 2 diabetes (T2D). Methods: In this cohort study, electronic health records from public primary and specialized healthcare services in all 13 municipalities of North Karelia, Finland, were utilized. This study included a total of 889 adults with newly diagnosed T2D in 2011 or 2012 (mean age at baseline 62.0 years). Individual BMI trajectories from the T2D diagnosis until 2014 were estimated and grouped by growth mixture modeling (GMM). Hazard ratios (HRs) with 95% confidence intervals (CIs) for microvascular complications, macrovascular complications, any diabetes complications, and all-cause mortality from 2015 to 2022 across BMI trajectory groups were estimated using Cox regression models. Results: Three distinct BMI trajectory groups were identified using GMM and labeled as follows: "stable" (n = 774, 87.1%), "decreasing" (n = 87, 9.8%), and "increasing" (n = 28, 3.1%). During a median follow-up of 8 years, there were 119 (13.3%) patients with microvascular complications, 187 (21.0%) with macrovascular complications, 258 (29.0%) with any diabetes complications, and 180 (20.2%) deaths. Compared with the "stable" BMI, the "increasing" BMI was associated with an increased risk of microvascular complications (HR = 2.88, 95% CI: 1.32 to 6.28), macrovascular complications (HR = 2.52, 95% CI: 1.17 to 5.43), and any diabetes complications (HR = 2.21, 95% CI: 1.16 to 4.20). The "decreasing" BMI was associated with an increased risk of all-cause mortality (HR = 1.90, 95% CI: 1.14 to 3.15), compared to the "stable" BMI. Conclusion: Our findings underscore the significance of continuous BMI monitoring and weight management in patients with T2D. Tailored treatments are crucial for efficiently preventing weight gain and reducing the risk of diabetes complications. Keywords: body mass index trajectory, type 2 diabetes, diabetes complications, all-cause mortality Most type 2 diabetes (T2D) patients live with obesity (body mass index, BMI ≥30 kg/m 2 ), 1 and weight loss is one of the therapeutic objectives in T2D management. 2,3 Clinical trials have demonstrated that modest weight loss, ie, 5‒10%, in T2D patients with high BMI improves the risk factors of diabetes complications, such as hyperglycemia, hyperlipidemia, and hypertension. 4,5 Complications arising from T2D can be categorized into microvascular complications, including retinopathy, neuropathy, and nephropathy, as well as macrovascular complications, such as cardiovascular disease, cerebrovascular disease, and peripheral vascular disease. 6,7 The association of BMI with microvascular complications and macrovascular complications in T2D patients has been investigated in observational studies. Some studies have reported a positive association, 8,9 while others have found either an inverse 10,11 or no association. 12,13 Furthermore, a meta-analysis including 16 cohort studies has reported a U-shaped relationship between the baseline BMI and total mortality among T2D patients, with the lowest risk observed at a BMI of 28‒30 kg/m 2 . 14 When these associations were estimated using baseline BMI alone, it neglects to take account of the fact that patients with T2D may experience BMI fluctuation over time. 15 Considering longitudinal BMI measurements, increasing evidence has demonstrated that high body weight variability is a risk factor for diabetes complications and all-cause mortality in American, 16,17 Korean, 18 and Swedish patients with T2D. 19 To emphasize the need for intensive support for weight management in diabetes care and inform the targeted treatment lines for T2D patients, the effects of longitudinal patterns of BMI change on health consequences in T2D patients should be investigated. To date, such investigations are still limited. To ou -Abstract Truncated-
public, environmental & occupational health